Share

Prevention and Early Detection

ACS CAN advocates for public policies that can prevent nearly half of all cancer deaths by ensuring access to recommended cancer screenings, protecting the public from skin cancer risk, reducing tobacco use and exposure to secondhand smoke and supporting people in increasing physical activity, eating a healthy diet, and managing their weight.

Prevention and Early Detection Resources:

Tobacco use causes about one-third of cancer deaths in the nation overall, but the burden varies by state.

The Centers for Disease Control and Prevention’s (CDC) National Breast and Cervical Cancer Early Detection Program (NBCCEDP) is highly effective at detecting and treating breast and cervical cancer in low-income, uninsured, and underinsured women – who may otherwise not be screened. The American Cancer Society Cancer Action Network (ACS CAN) urges Congress to reauthorize this critical program by passing the Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act.

A critical factor for eliminating disparities and ensuring health equity is the guarantee that all people have access to quality, affordable health care.

In 2024, an estimated 13,820 people in the U.S. will be diagnosed with invasive cervical cancer, and 4,360 will die from the disease. Cervical cancer can affect any person with a cervix and most often is caused by certain types of human papillomavirus (HPV). Persistent HPV infection causes almost all cervical cancers but fortunately there is a safe and effective vaccine against HPV.

Breast cancer is the most commonly diagnosed cancer and the second-leading cause of cancer death in women. Although incidence rates have increased slightly over the past decade, death rates from breast cancer have been consistently declining over the last three decades, largely due to increased screening rates and improved treatment.

ACS CAN calls on the administration to finalize FDA’s rules to prohibit the sale of menthol cigarettes and flavored cigars immediately. There is no scientific rationale for permitting any flavored tobacco product to remain on the market. To end cancer as we know it for everyone, tobacco use must be addressed and cannot be done without prohibiting the sale of menthol flavors and all flavored cigars.

Our latest survey finds that protecting no-cost screenings and preventive care and reducing the burden of medical debt are the most impotant priorities for cancer patients and survivors. This survey also explores the impacts of cancer on food and nutrition insecurity, with impacts felt across income groups and coverage levels.

The American Cancer Society Cancer Action Network (ACS CAN) believes everyone should have a fair and just opportunity to prevent, detect, treat, and survive cancer. No one should be disadvantaged in their fight against cancer because of income, race, gender identity, sexual orientation, disability status, or where they live. From preventive screening and early detection, through diagnosis and treatment, and into survivorship, there are several factors that influence cancer disparities among different populations across the cancer continuum.

Eliminating tobacco-related disparities requires that Medicaid enrollees have access to comprehensive cessation benefits without cost-sharing or other barriers to quit tobacco.

Tobacco Control Resources:

Research has repeatedly shown that there is no risk-free level of exposure to secondhand smoke (SHS). Smoke-free laws and policies provide immediate and long-term health benefits for both people who smoke and those who do not and are good for businesses and workers.

Exposure to secondhand smoke (SHS) is an occupational hazard for many casino workers – from dealers to security. But when smoking is permitted in casinos, no one – even patrons – is safe from SHS exposure. Job-related exposure to SHS is a significant, but entirely preventable, cause of premature death among U.S. workers.

 

ACS CAN and 77 leading public health organizations urged the U.S. Food and Drug Administration (FDA), and its enforcement partners at the U.S. Department of Justice (DOJ) and the U.S. Customs and Border Protection (CBP), to use all the enforcement tools at their disposal against manufacturers, distributors, wholesalers and retailers to clear the market of unauthorized e-cigarette products, including flavored products that put young people at risk for nicotine addiction and other significant health harms.

Tobacco use causes about one-third of cancer deaths in the nation overall, but the burden varies by state.

All tobacco products, including heated tobacco products, are unsafe. Heated tobacco products involve heating rather than burning the tobacco leaf, which is why the tobacco industry refers to them as “heat-not-burn” or non-combustible cigarettes. These products differ from e-cigarettes which heat a liquid.

ACS CAN calls on the administration to finalize FDA’s rules to prohibit the sale of menthol cigarettes and flavored cigars immediately. There is no scientific rationale for permitting any flavored tobacco product to remain on the market. To end cancer as we know it for everyone, tobacco use must be addressed and cannot be done without prohibiting the sale of menthol flavors and all flavored cigars.

When faced with mounting evidence that tobacco tax increases effectively reduce tobacco use, tobacco manufacturers will try to distract policymakers from the material facts by invoking dire warnings of reduced revenue due to increased illicit activity including widespread smuggling and other organized crime that they claim will result from increased taxes on cigarettes and other tobacco products.

Pharmacies can offer an additional opportunity to aid individuals wanting to quit tobacco by providing immediate support and access to FDA-approved cessation medications.

Eliminating tobacco-related disparities requires that Medicaid enrollees have access to comprehensive cessation benefits without cost-sharing or other barriers to quit tobacco.

Screening Resources:

ACS CAN supports the Women and Lung Cancer Research and Preventive Services Act of 2023 by to accelerate progress in reducing mortality from lung cancer, including among women.

Our ability to continue to make progress against cancer relies heavily on eliminating inequities that exist in breast cancer prevention and treatment. That is why ACS CAN advocates for policies to reduce the disparities in breast cancer by improving access to prevention and early detection services, patient navigation services, insurance coverage, in-network facilities, and clinical trials.

The Centers for Disease Control and Prevention’s (CDC) Colorectal Cancer Control Program (CRCCP) provides grant funding to 20 state health departments, eight universities, two tribal organizations, and five other organizations to help prevent colorectal cancer, the third most common cancer in men and women and the second leading cause of cancer death in the U.S. for men and women combined.

Our latest survey finds that cancer patients and survivors would be less likely to stay current with preventive care, including recommended cancer screenings, if the provision requiring these services be covered at no cost were repealed. This survey also explores the challenges of limited provider networks and the need for patient navigation.

Prostate cancer is the most common cancer in Black men. Black men are over twice as likely to die from prostate cancer compared to every other racial and ethnic group and they are also more likely to be diagnosed at an advanced stage. Black men with lower-grade (less aggressive) disease are actually more likely to die from prostate cancer than white men. The reasons for this are complex and include interactions between social, behavioral and biological factors.

 

Colorectal cancer is the third most common cancer in men and women and the second leading cause of cancer death in men and women combined in the United States. Yet, about 1 in 3 adults aged 50 to 75 are not getting tested as recommended. This factsheet discusses the importance of screening for colorectal cancer and what can be done to improve screening in the U.S.

In the U.S., colorectal cancer is the third leading cause of cancer-related deaths in men and in women, and the second most common cause of cancer deaths when men and women are combined. Despite advancements in screening and treatment, CRC does not affect every community the same. 

  •  

Healthy Eating and Active Living Resources:

ACS and ACS CAN submitted comments and recommendations regarding the White House Conference on Hunger, Nutrition, and Health, planned to be held in September 2022.

ACS and ACS CAN submitted comments on Topics and Scientific Questions for the 2025-2030 Dietary Guidelines for Americans.

  •